抄録
OBJECTIVE. The purpose of this study was to determine whether quantitative pulmonary perfusion parameters obtained from 3D dynamic contrast-enhanced MR perfusion data can be used to assess the severity of primary pulmonary hypertension (PPH) as indicated by pulmonary vascular resistance (PVR) and mean pulmonary artery pressure (MPAP). CONCLUSION. Three-dimensional dynamic contrast-enhanced MRI has potential for assessment of disease severity as indicated by PVR and MPAP in patients with PPH.
本文言語 | 英語 |
---|---|
ページ(範囲) | 48-56 |
ページ数 | 9 |
ジャーナル | American Journal of Roentgenology |
巻 | 188 |
号 | 1 |
DOI | |
出版ステータス | 出版済み - 01-2007 |
外部発表 | はい |
All Science Journal Classification (ASJC) codes
- 放射線学、核医学およびイメージング